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The aims of this study were to characterize reinforced metal-oxide-semiconductor 
field-effect transistor (MOSFET) dosimeters to assess the measurement uncertainty, 
single exposure low-dose limit with acceptable accuracy, and the number of expo-
sures required to attain the corresponding limit of the thermoluminescent dosimeters 
(TLD). The second aim was to characterize MOSFET dosimeter sensitivities for 
two dental photon energy ranges, dose dependency, dose rate dependency, and 
accumulated dose dependency. A further aim was to compare the performance 
of MOSFETs with those of TLDs in an anthropomorphic phantom head using a 
dentomaxillofacial CBCT device. The uncertainty was assessed by exposing 20 
MOSFETs and a Barracuda MPD reference dosimeter. The MOSFET dosimeter 
sensitivities were evaluated for two photon energy ranges (50–90 kVp) using a 
constant dose and polymethylmethacrylate backscatter material. MOSFET and TLD 
comparative point-dose measurements were performed on an anthropomorphic 
phantom that was exposed with a clinical CBCT protocol. The MOSFET single 
exposure low dose limit (25% uncertainty, k = 2) was 1.69 mGy. An averaging of 
eight MOSFET exposures was required to attain the corresponding TLD (0.3 mGy) 
low-dose limit. The sensitivity was 3.09 ± 0.13 mV/mGy independently of the 
photon energy used. The MOSFET dosimeters did not present dose or dose rate 
sensitivity but, however, presented a 1% decrease of sensitivity per 1000 mV 
for accumulated threshold voltages between 8300 mV and 17500 mV. The point 
doses in an anthropomorphic phantom ranged for MOSFETs between 0.24 mGy 
and 2.29 mGy and for TLDs between 0.25 and 2.09 mGy, respectively. The mean 
difference was -8%. The MOSFET dosimeters presented statistically insignificant 
energy dependency. By averaging multiple exposures, the MOSFET dosimeters 
can achieve a TLD-comparable low-dose limit and constitute a feasible method 
for diagnostic dosimetry using anthropomorphic phantoms. However, for single 
in vivo measurements (<1.7 mGy) the sensitivity is too low.
PACS number: 87.50.wj 
Key words: MOSFET dosimeter, X-ray, radiation exposure
 
JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 16, NUMBER 4, 2015
266   266
267  Koivisto et al.: MOSFET dosimeter evaluation 267
Journal of Applied Clinical Medical Physics, Vol. 16, No. 4, 2015
I. INTRODUCTION
Monitoring of the radiation exposure induced by dental examinations has become more important 
due to the rapidly increasing number of X-ray devices in use. Cone-beam computed tomography 
(CBCT) devices are becoming more commonly used and cause substantially higher patient 
doses(1) when compared with conventional dental radiography devices.
To date, most studies concerning effective dose assessment have used thermoluminescent 
dosimeters (TLD) in combination with anthropomorphic phantoms.(2-7) The low-dose limit of 
TLDs when using single exposure (0.3 mGy)(8,9) has been considered adequate in most appli-
cations and has, therefore, been used as the reference low-dose limit in MOSFET uncertainty 
assessment in this study. The main drawback with using TLDs is that they need to be replaced 
and read after every exposure. This can become tedious and time-consuming when a series of 
different measurements are performed. 
One possible alternative to TLDs is Metal Oxide Semiconductor Field Effect Transistor 
(MOSFET) dosimeters that can be used for near real-time, point-dose measurements in anthro-
pomorphic phantoms. Until recently, MOSFETs were mainly used in radiotherapy,(10-13) but are 
now being more commonly used in different fields of diagnostic radiology.(14-18) A drawback with 
MOSFET dosimeters is that they have limited sensitivity when compared with TLD dosimeters. 
To date, most studies focusing on MOSFET characterization of diagnostic radiology use 
TLDs.(9,13,19) MOSFET dosimeters should ideally be characterized similarly to TLDs, and 
calibrated at the radiation qualities close to those for which measurements are needed.(20) 
A more recent study by Manninen et al.(21) evaluated MOSFET dose linearity, repeatability 
and sensitivity using tube voltages between 40–125 kVp. They used radiophotoluminescence 
dosimeters (RPLD) instead of TLDs to characterize MOSFET (TN-1002RD) dosimeters that 
have different attenuation properties than the reinforced dosimeter type (TN-1002RD-H) used 
in this study. In their study, Manninen et al. focused on characterizing MOSFETs, using two 
different conventional radiographic devices (Philips Optimus 50, Siemens Axion Aristos FX) 
and with different aluminum filters. 
Low-dose inaccuracies can have a negative effect on the outcome of the measurements 
when using MOSFETs for diagnostic purposes. The main cause for the low-dose inaccuracies 
is type A (statistical) uncertainty that can be improved by increasing the number of exposures 
and subsequently averaging the results.(22) However, multiple exposures can only be performed 
on anthropomorphic phantoms and not as in vivo measurements on patients.
This study has three main aims. The first aim was to characterize the MOSFET dosimeter 
uncertainty and to calculate the single exposure low dose limit and to subsequently determine the 
number of exposures required to attain (25% uncertainty, k = 2) the TLD comparable (0.3 mGy) 
low-dose limit. A second aim was to characterize MOSFET dosimeter sensitivities for two 
energy ranges using a dental and maxillofacial CBCT device. The mean photon energies were 
attained using two different filter combinations. Furthermore, the MOSFET dosimeters were 
characterized for dose dependency, dose rate dependency, and accumulated dose dependency. 
The final aim was to compare the point-dose measurement performance of MOSFETs with 
those of TLDs in an anthropomorphic phantom using dental and maxillofacial CBCT imaging. 
 
II. MATERIALS AND METHODS
A.  Scanner
All measurements were performed using a ProMax 3D MID dental cone-beam computed 
tomography (CBCT) device (Planmeca, Helsinki, Finland). The radiation source contained a 
Toshiba D-054 X-ray tube (Toshiba Electron Tubes & Devices Co., Ltd. Otawara-shi, Japan) 
with tungsten (W) target, 5° anode angle, 0.5 mm Al-equivalent inherent filtration, and a 0.5 mm 
focal spot size. The tube potentials ranged from 50 kVp to 90 kVp, with 5 kV increments, to 
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encompass the typical energy ranges used in dental diagnostic procedures. MOSFET sensitivities 
were assessed using two different filter combinations (2.5 mm Al, and 2.5 mm Al + 0.5 mm Cu) 
to reproduce two different commonly used dental energy spectra. The X-ray spectra, expressed 
in terms of the half value layer (HVL) and the average photon energy (Table 1) were calculated 
using a computer program(23) that was based on the semi-empirical spectrum model described 
by Birch and Marshall.(24)
B. Dosimeters
B.1 MOSFET reader system 
The TN-RD-70-W20 MOSFET device comprises a TN-RD-38 wireless Bluetooth transceiver, 
four TN-RD-16 reader modules, twenty high-sensitivity TN-1002RD-H dosimeters, and 
TN-RD-75M software (Best Medical, Ottawa, ON, Canada). In this study, TN-RD-16 reader 
modules that can be independently set to control five dosimeters were operated using the high 
bias voltage, 13.6 V, to obtain the best possible accuracy. A TN-RD-38 Bluetooth transceiver 
was used for data communication between the TN-RD-16 reader modules and a PC.
B.2 MOSFET dosimeters 
MOSFET dosimeter (TN-1002RD-H) comprises an n-type semiconductor substrate that is 
isolated from the metal gate (G) by a very thin silicon oxide (SiO
2
) layer (Fig. 1(a)). Ionizing 
radiation causes the generation of electron hole pairs in the SiO
2
 layer. Some of the holes near 
the Si-SiO
2
 interface are trapped causing a stable negative shift (DVTH) for a predetermined drain (D) – source (S) current (IDS) that is proportional to the radiation dose. The MOSFET dosimeter operating principles have been reported by several investigators.(8,25,26) The TN-1002RD-H 
dosimeter used in this study comprised two MOSFETs with an active area 0.04 mm3 that were 
Table 1. The calculated mean photon energies and corresponding Cu HVLs, using 2.5 mm Al filter and 2.5 mm 
AL+0.5 mm Cu filter combinations. 
 Tube Al (2.5 mm) Al (2.5 mm) + Cu (0.5 mm)
 Voltage Mean E HVL Mean E HVL
 kV keV Cu (mm) keV Cu (mm)
 50 34.2 0.072 41.2 0.161
 55 36.4 0.081 44.2 0.192
 60 38.6 0.093 46.9 0.224
 65 40.7 0.104 49.6 0.258
 70 42.8 0.115 52.2 0.294
 75 45.0 0.129 54.7 0.333
 80 47.1 0.144 57.1 0.373
 85 49.0 0.159 59.2 0.411
 90 50.8 0.176  61.1 0.448
Fig. 1. p-channel MOSFET dosimeter (a) structure and TN-1002RD-H dosimeter (b).
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fabricated on a silicon rectangle (a die) mounted on a flexible polyamide (PCB) cable and 
encapsulated with black 1.02 mm thick(21) epoxy resin (Fig. 1(b)).  
B.3 TLD dosimeters
Forty TLD thermoluminescent dosimeters (TLD 100; Thermo Fisher Scientific, Waltham, MA) 
were used to compare their performance with MOSFETs in an anthropomorphic RANDO phan-
tom (The Phantom Laboratory, Salem, NY). The reset and annealing procedures of the TLDs 
were made in a microprocessor-controlled TLD oven (PTW, Freiburg, Germany). The TLD 
read-out sequence was performed in a Fimel LTMWin (Fimel, Fontenay-aux-Roses, France) 
device. TLD calibration and read-out procedures were performed according to a method previ-
ously described by Rottke et al.,(7) with traceability to secondary standard dosimetry laboratory 
(SSDL, Freiburg, Germany).
B.4 Reference dosimeters
A Barracuda multipurpose detector (RTI Electronics AB, Mölndal, Sweden) with a measurable 
dose range between 0.1 μGy–1000 Gy and less than ± 1% energy sensitivity variation between 
50–90 kVp was used as a reference dosimeter. Reference readings of all energy sensitivity mea-
surements were attained using a RADCAL 1015 dosimeter and a RADCAL 10X5-6 ionization 
(Radcal Corporation, Monrovia, CA) chamber with less than ± 1% energy sensitivity variation 
in the 30–70 keV range used in this study. Prior to the measurements, both the Barracuda MPD 
and the RADCAL 1015 dosimeters were calibrated at the secondary standard dosimetry labora-
tory (SSDL) of the Finnish Radiation and Nuclear Safety Authority (STUK) that is traceable 
to primary standard dosimetry laboratory (PSDL). 
C.  Phantom
In the second part of the study, an anthropomorphic RANDO RAN102 male head phantom (Fig. 2) 
(Radiation Analogue Dosimetry System; The Phantom Laboratory) was used for the comparative 
dose measurements between TLD and MOSFET dosimeters. The phantom represents an adult male 
that comprises a human skull embedded in a soft tissue-equivalent synthetic material to match 
the attenuation and scattering properties of the bone, soft tissues, and airways of the human head. 
The phantom was transected into ten 2.5 cm thick layers each comprising a 1.5 cm × 1.5 cm grid 
of ϕ 0.5 cm holes filled with removable, soft tissue-equivalent plugs for dosimeter placement.
Fig. 2. The MOSFET measurement system with four TN-RD-16 reader modules, RANDO phantom, and ProMax 3D 
MID CBCT device.
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D.  Measurements
D.1 MOSFET dosimeter uncertainty
In this study, the MOSFET dosimeter uncertainty was assessed according to the UK National 
Dose protocol,(27) where the maximum patient dose uncertainty has been proposed to be 25% 
at 95% confidence level. In order to evaluate the uncertainty, all MOSFET and Barracuda 
dosimeters were simultaneously exposed to 80 kVp (47.1 keV, HVL 7.71 mm Al, SID 600 mm) 
using a Promax 3D CBCT device (Planmeca Oy, Helsinki, Finland) with a 2.5 mm Al filter. 
The X-ray source was operated without gantry rotation, using seven mAs values (10, 20, 40, 
80, 160, 320, and 640 mAs). The corresponding doses were 0.24, 0.52, 1.1, 2.2 4.4, 8.8, and 
17.6 mGy, respectively.
The Barracuda MPD dosimeter calibration coefficient, 1.018, for 80 kVp tube voltage, 2.5 mm 
Al + 0.5 mm Cu, was used to convert the dosimeter reading to the true dose. The calculated 
expanded uncertainty (2 SD) of the Barracuda MPD using ten averaged samples (80 kVp) was 
1.1%. The combined uncertainty (u
c
) was calculated as quadratic summation of uncertainties of 
Barracuda MPD and MOSFET readout uncertainties (k = 2). Furthermore, the lowest accept-
able dose and required number of samples to attain 0.3 mGy low-dose limit were assessed.
The combined uncertainties (u
c
) of photon energy sensitivity measurements were assessed 
as a weighted sum of variances. These included RADCAL calibration dosimeter expanded 
(2 SD) energy sensitivity uncertainty 2% (30–70 keV) obtained from RADCAL 1015 datasheet, 
MOSFET dosimeter calibration factor variation as function of saturation voltage (4%),(28) esti-
mated position induced uncertainty (2%), and cable irradiation uncertainties (1%) according 
Ehringfelt et al.(29)  
The MOSFET and TLD point-dose CBCT measurement combined uncertainty (u
c
) was 
calculated as the weighted sum of variances including the statistical measurement uncer-
tainty, dosimeter and phantom positioning uncertainties (10%, 10%),(30) MOSFET dosimeter 
calibration factor variation (4%),(31) X-ray source variation (5%),(28) and cable irradiation 
uncertainty (1%).(29)
D.2 Photon energy sensitivity
The photon energy sensitivity measurements were performed using 20 MOSFET dosimeters 
that were attached to an in-house made carbon fiber frame. The MOSFET positions were care-
fully chosen as a linear array perpendicular to anode–cathode direction to minimize the heel 
effect in the anode–cathode direction. Furthermore, the subgroups of ten dosimeters on both 
sides of the RADCAL 10 × 5-6 ionization chamber (Fig. 3) were interchanged to compensate 
for possible variations in dose across the field. The measurements were repeated ten times and 
an average calibration coefficient (mV/mGy) was calculated. In order to include the backscatter 
radiation, a 15 cm × 15 cm × 10 cm thick PMMA block was attached to a carbon fiber holder 
Fig. 3. MOSFET dosimeter energy dependency measurement setup with a PMMA backscatter block. 
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to simulate soft tissue interactions.(32) The PMMA block dimensions were chosen based on a 
study by Khan(33) and were, therefore, considered to provide sufficient backscatter for the Cu 
HVLs (mm) used in this study (Table 1).
The measurements were carried out using a Promax 3D CBCT device operated without gantry 
rotation and constant doses to minimize possible dose or angular dependency (Al 2.5 mm filter: 
17.6 ± 0.2 mGy, Al 2.5 mm + 0.5 Cu: 20.6 ± 0.4 mGy). The tube voltage range was 50–90 kVp 
with 5 kVp increments. The calculated photon energy spectra and tube voltages (kVp) used 
are presented in Table 1.
MOSFET calibration coefficient (CF), mV/mGy, was determined as the MOSFET reading 
(mV) divided by the dose measured with the RADCAL 1015 reference dosimeter.(34) Sensitivities 
for each MOSFET dosimeter were calculated separately. The sensitivity differences between 
the dosimeters were minimal, and thus the average sensitivity result was finally presented.
D.3 Dose dependency 
The 20 dosimeters were irradiated ten times on the Promax 3D CBCT device. All exposures 
were performed using 80 kVp with a 2.5 mm Al filter and seven different mAs values (10, 
20, 40, 80, 160, 320, and 640 mAs) over a dose range from 0.24 to 17.5 mGy. The average 
dosimeter responses were calculated for each dosimeter and dose value. 
D.4 Dose rate dependency
The dose rate dependency was evaluated by exposing 20 MOSFET dosimeters using a Promax 
3D CBCT device (80 kVp, 2.5 mm Al filter, 47.1 keV). All exposures were performed using a 
constant dose of 16.4 mGy with five different dose rates (0.16, 0.32, 0.67, 1.34, and 2.70 mGy/s). 
The mean dose rate dependency was calculated for each dosimeter and dose rate.
D.5 MOSFET accumulated dose dependency
In order to assess the MOSFET dosimeter accumulated dose sensitivity the following calibra-
tion setup was used: 80 kVp, 2.5 mm Al, 47.1 keV, 17.6 mGy, PMMA. The sensitivity of the 
20 MOSFET dosimeters was measured after dismantling the dosimeters from the phantom at 
a 17.500 mV accumulated threshold voltage. The MOSFET sensitivity as a function of the 
accumulated dose was calculated based on the differences attained at two different threshold 
voltages: 8300 mV (after the calibration procedure) and 17.500 mV (after dismantling the 
dosimeters from the phantom).
 
D.6 MOSFET-TLD point-dose assessment
MOSFET and TLD comparison measurements were performed using a ProMax 3D MID CBCT 
device (Fig. 3) (face–maxillofacial protocol, FOV 20 cm × 17 cm). All exposures were carried 
out using 90 kVp tube voltage (2.5 mm Al + 0.5 mm Cu filter, 61.1 keV), 6 mA tube current, 
and 18 s exposure time (108 mAs).
The point doses were obtained using 40 TLDs and 20 MOSFETs that were alternately placed 
in 20 locations in an anthropomorphic RANDO phantom that represented, according to a previ-
ous study,(28) the most radiosensitive organs in the maxillofacial region. Two TLD dosimeters 
were placed in each anatomic site to calculate the mean value of each specific location. All 
MOSFET measurements and corresponding read-outs were repeated ten times to calculate the 
average dose. Furthermore, all TLDs were exposed ten times and the average dose was calcu-
lated from the single read-out. The dose difference between the MOSFET and TLD dosimeters 
was calculated as follows: Difference (%) = (MOSFET-TLD)/TLD. 
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III. RESULTS 
A.  Uncertainty 
The type A standard uncertainty (Error%) was assessed for six dose levels. The uncertainties 
of the ten repeated measurements were evaluated for each dose using 95% confidence interval 
(k = 2). The combined uncertainty at 95% confidence at different doses were fitted into an 
exponential function and resulted in the following equation:
 Err(D) = (0.2853* D–0.6924 + 0.0518)* n–0.5 (1)
where D is dose in (mGy) and n is the number of samples (exposures). The coefficient of deter-
mination was R2 = 0.99. The single sample (n = 1) low-dose limit for the MOSFET dosimeter 
was 1.7 mGy (Fig. 4).  
Furthermore, solving Eq. (1) for number of samples (n) and setting dose (D) to the TLD 
low-dose limit (0.3 mGy), according to Tarr et al.(8) and Dong et al.,(9) resulted in a total of 
eight averaged MOSFET samples. 
B.  Photon energy sensitivity
The MOSFET sensitivity measured with different filtrations was 3.10 ± 0.10 mV/mGy and 
3.08 ± 0.14 mV/mGy using 2.5 mm Al and 2.5 mmAl + 0.5 Cu filter combinations, respectively. 
The photon energy sensitivities (mV/mGy), relative energy sensitivities using 2.5 mm Al filter, 
and 2.5 mm Al + 0.5 mm Cu filter combinations with standard deviation (1 SD) are presented 
in Figs. 5 and 6. The MOSFET dosimeter sensitivity was not statistically dependent on the 
chosen kVp or the filtration according to two-tailed Student’s t-test (p = 0.75) and Pearsons 
correlation (pAl = 0.81, pAl+Cu =0.17).    
 
Fig. 4. The combined uncertainty (%) of MOSFET dosimeters as a function of dose and number of averaged samples 
(n = 1–16), 1.7 mGy one exposure low dose limit, and TLD comparable (0.3 mGy) low-dose limit.
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C.  Dose dependency
The MOSFET dosimeter dose dependency was statistically insignificant with the following 
linear regression: y =1.003x + 0.0396. The MOSFET dosimeters showed a good correlation 
with the Barracuda MPD reference dosimeter (R2 = 0.99987). The standard deviation of the 
dose dependency measurements ranged from 2.4% to 12.5%.
D.  Dose rate dependency
The MOSFET dosimeter sensitivity was 3.14 ± 0.11 mV/mGy for all evaluated dose rates 
(0.16–2.70 mGy/s).  
E.  MOSFET accumulated dose dependency
Based on the calibration measurements, the average MOSFET dosimeter sensitivity was 3.10 ± 
0.10 mV/mGy at 8.300 mV accumulated threshold voltage. The new calibration resulted in 
2.83 ± 0.12 mV/mGy sensitivity at 17.500 mV accumulated threshold voltage. The average 
sensitivity decrease was 9.4% over 9200 mV (17.500-8.300 mV) threshold voltage variation. 
The MOSFET sensitivity decrease rate caused by the accumulated dose was 1.02% per 1000 mV.
Fig. 5. MOSFET dosimeter sensitivity (mV/mGy) using a 2.5 mm Al filter with corresponding error bars (1 SD).
Fig. 6. MOSFET dosimeter sensitivity (mV/mGy) using a 2.5 mm Al + 0.5 mm Cu filter with corresponding error bars 
(1 SD).
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F.  MOSFET and TLD comparison point-dose assessment
The MOSFET organ doses ranged between 0.24 mGy and 2.29 mGy and the TLD doses between 
0.25 and 2.09 mGy. The mean difference between the MOSFET and the TLD dosimeters was 
-8%. The average point doses (mGy), differences (%), and the combined uncertainties (u
c
) 
attained by the dosimeters located in the different layers (no.) of the anthropomorphic phantom 
using CBCT measurements are presented in Table 2.
 
IV. DISCUSSION
A.  MOSFET dosimeter uncertainty 
In the present study, the MOSFET dosimeter uncertainty was evaluated to define the single 
sample low-dose limit (25% uncertainty, k = 2) and to assess the number of exposures needed 
to attain the previously proposed TLD (one exposure) low-dose (0.3 mGy) limit. The purpose 
of this study was also to assess the MOSFET sensitivity for different energy ranges and to 
compare the MOSFET point-dose results with those obtained using TLDs.
According to our study, the TLD comparable lowdose limit (0.3 mGy) can be achieved by 
averaging eight MOSFET exposures. However, an increase in the number of exposures results 
in a higher dose and cannot, therefore, be used for in vivo dose measurements in order to com-
ply with the ALARA principle (as low as reasonably achievable). Thus, the use of MOSFET 
dosimeters should only be used for phantom measurements in dentomaxillofacial radiology.
When comparing the single sample low-dose detection limit of MOSFET dosimeters 
(1.40 mGy) attained by Yoshizumi at al.(35) with the dose obtained in this study (1.69 mGy), the 
results showed a 21% higher dose value. The difference in results could be caused by MOSFET 
sensitivity decrease due to a higher 120 kVp compared to the 80 kVp used in this study. In a 
prior study performed by Peet and Pryor,(13) the observed minimum (25% total uncertainty, 
k = 2) was 1.5 mGy dose when MOSFET detectors were evaluated for entrance surface dose 
Table 2. Average of ten absorbed dose measurements, difference (%) between MOSFET and TLD values, and com-
bined MOSFET uncertainties.
  MOSFET TLD Difference MOSFET
 Organ (layer no.) (mGy) (mGy) (%) u
c
 Calvarium anterior (2) 1.25 1.20 3%   18%  
 Mid brain (3) 1.09 1.36 -20%   18%  
 Pituitary fossa (3) 1.35 1.29   5%   18%  
 Right orbit (4) 1.65 2.04 -19%   17%  
 Right lens (4) 2.29 2.05 12%   16%  
 Right cheek (5) 1.44 2.06 -30%   17%  
 Right ramus (7) 1.05 1.54 -32%   18%  
 Left ramus (7) 1.49 1.98 -25%   17%
 Right parotid (6) 1.20 1.45 -17%   18%
 Left parotid (6) 1.28 1.66 -23%   18%  
 Center C-spine (7) 1.10 1.26 -13%   18%  
 Left back neck (8) 0.36 0.39 -8%   25%  
 Right mandible body (7) 1.42 1.41 0%   17%  
 Left mandible body (7) 1.42 1.62 -12%   17%  
 Right submandibular gland (8) 1.13 0.52 118%   18%  
 Left submandibular gland (8) 1.15 0.57 103%   18%  
 Center sublingual gland (8) 0.46 0.58 -20%   23%  
 Midline thyroid (9) 0.33 0.32 3%   26%  
 Thyroid surface  (9) 0.24 0.25 -4%   30%  
 Pharyngeal-oesophageal space (9) 0.29 0.33 -12%   27%  
 Average 1.10 1.19  20%
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measurements. Their 11% lower value could have been caused by the water backscatter material 
which has a lower backscatter factor (BSF) than the PMMA used in this study. 
B.  Photon energy sensitivity 
We showed that the MOSFET dosimeter sensitivity was independent of the photon energy by 
using two filter combinations and tube potentials between 50 kVp and 90 kVp. A recent study 
by Manninen et al.(21) investigated the MOSFET (TN-1002RD) energy dependency using 
tube potentials between 40 kVp and 125 kVp. Compared with the reference dosimeter value, 
they observed a 6% coefficient of variation for tube potentials between 60 and 110 kVp, a 
-10% decrease at 40 kVp, and a -14.6% decrease at 125 kVp, respectively. These differences 
can be explained by the lower number of exposures applied (five versus ten), the lower dose 
(5 mGy versus 17 mGy/20 mGy) affecting the uncertainty, different mean photon energy range 
(keV), and finally by the backscatter material thickness (10 mm) that was used in their study. 
Furthermore, another factor that could help explain the differences may have been the differ-
ent dosimeter attenuation characteristics caused by the reinforcement of the dosimeter type 
(TN-1002RD-H) used in this study. 
In an earlier study by Dong et al.,(9) the photon energy response of MOSFET dosimeters 
were evaluated for skin dose measurements using tube voltages between 40 and 125 kVp (E
ave
= 
26.5–39.7 keV). Their study resulted in a 20% decrease in sensitivity from 40 kVp to 90 kVp. 
The different energy range and the water backscatter material used by Dong and colleagues 
may well explain the differences when compared to the statistically insignificant sensitivity 
variations observed in our study. Furthermore, a study by Peet and Pryor(13) evaluated the energy 
sensitivity of MOSFETs over a range of 60–100 kVp for diagnostic purposes. The photon energy 
sensitivity varied between 2.2 mV/mGy–2.9 mV/mGy. The results of their study showed -20% 
lower sensitivity at 60 kVp compared to the (normalized) 90 kVp value. The lower sensitivity 
results may have been caused by the different orientation of the MOSFET epoxy bulbs that faced 
towards the water backscatter material. In our study, the epoxy bulbs were directed towards the 
X-ray source to attain the highest sensitivity, based on a previous study by Koivisto et al.(22) 
Furthermore, Bower and Hinterlang(19) characterized MOSFET dosimeter energy dependency 
using a (roughly) constant dose and a tube voltage ranging between 40–140 kVp. Their choice 
of the constant dose, PMMA backscatter material, and RADCAL 1015 reference dosimeter 
resulted in comparable values to those attained in our study when the results of both studies 
were normalized to 90 kVp tube voltage.
Even though backscattering is always present in phantom measurements, additional evalua-
tions of the photon energy sensitivities were performed without the PMMA backscatter material 
(free-in-air). Based on the result of the evaluations, the backscatter factor (BSF) could also be 
determined. The measurements resulted in 17% higher response at 50 kVp compared to the 
normalized 90 kVp value and in BSF comparable to the findings of Khan.(33) This variation 
in results indicates that when MOSFETs are used with phantoms, as in our study, the energy 
dependency should be evaluated using proper backscatter conditions because the scattered 
X-rays emphasize the lower energy contribution of the net photon spectrum detected by the 
MOSFET dosimeter.
C.  Dose dependency 
The MOSFET dosimeter dose dependency was evaluated using 0.24–17.5 mGy. The MOSFET 
dosimeters can be used without dose dependency correction factors for low-dose (< 17.5 mGy) 
measurements. The results were comparable with the findings of Dong et al.(9) and Bower 
and Hinterlang.(19)
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D.  Dose rate dependency
The MOSFET dose rate dependency was assessed using 0.16–2.70 mGy/s dose rates. No 
statistically significant variation in the sensitivity at different dose rates were observed and, 
therefore, no dose rate correction was needed.(36)
E.  MOSFET accumulated dose dependency
The MOSFET sensitivity as a function of the accumulated dose was assessed over a 9.200 mV 
threshold voltage range. This resulted in a 1% decrease of sensitivity per 1000 mV thresh-
old voltage which is in good agreement with the findings of Brady and Kaufmann(34) and 
Toncheva et al.(31)  
F.  MOSFET and TLD comparison 
The point doses obtained in the anthropomorphic RANDO phantom using MOSFET dosimeters 
resulted in a -8% lower average point dose (1.10 mGy) value than that obtained using TLD 
dosimeters (1.19 mGy). This -8% difference can be explained by a loss of MOSFET sensitiv-
ity previously described Brady and Kaufmann(34) (≈ 1% per 1000 mV) and Toncheva et al.(31) 
(≈ 3% per 3000 mV), and by the accumulated (> 10.000 mV) average threshold voltage used 
in the phantom measurements of this study. The dosimeter (1 SD) uncertainties in the phan-
tom measurements ranged between 26% (0.24 mGy) and 7% (2.29 mGy) using ten averaged 
samples (Table 2). Furthermore, the combined (point dose) (1 SD) uncertainty, calculated as 
the weighted sum of variances, ranged between 17% and 30%. All TLD and MOSFET point-
dose values, except for those in the left and right submandibular glands, were within the range 
covered by the extended (2 SD) combined MOSFET uncertainty (U
c
). The higher MOSFET 
doses observed in the left and right submandibular glands could be due to the vertical position 
variations of the dosimeters in their designated phantom holes; the surrounding mandible bones 
may have caused different attenuation and scatter profiles to the dosimeters.
In this study, there were certain limitations. One limitation of the study was that the MOSFET 
dosimeter performance was not specifically evaluated for clinical applications such as entrance 
skin dose. Furthermore, the individual MOSFET threshold voltages should have been registered 
and used for calibration coefficient corrections during the measurements in order to improve 
the accuracy of the results. When purchasing new dosimeters, calibration is required which 
subsequently limits the lifespan of the MOSFET dosimeter due to their saturation.
 
V. CONCLUSIONS
The MOSFET dosimeters presented statistically insignificant energy dependency for the inves-
tigated dental energies. However, the MOSFET dosimeters are not recommended for in vivo 
studies when assessing doses lower than 1.7 mGy since they fail to provide conformance with 
the target minimum uncertainty of 25% (k2). Nevertheless, the MOSFET dosimeters constitute 
a feasible dose assessment method for low-dose (<1.7 mGy) CBCT anthropomorphic measure-
ments using multiple sampling and averaging the results. 
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